Protocol Design White Papers & Case Studies
-
Human Abuse Potential
4/17/2024
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Patient Engagement: Early Cancer Detection Blood Draw
4/17/2024
Discover how we aided a pharmaceutical company in enrolling participants for a Phase III trial, DETECT-ASCEND 2, focused on Plasma-Based CancerSEEK Testing for early cancer detection.
-
Cystic Fibrosis: Global Clinical Trial Landscape (2024)
4/8/2024
Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.
-
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)
4/8/2024
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Patient Caregiver Network Improves Post-Seizure Trial Data
3/26/2024
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
Study Start-Up Challenges: Hard Realities, Effective Strategies
3/13/2024
Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?
-
Precision Oncology Clinical Trials And Statistics 2024
3/12/2024
Delve into the latest advancements in clinical trials, targeted therapies, and the promising horizon of cancer care.
-
Quality By Design: Better Data Using Participant Insights
3/12/2024
While clinical trials will always encounter challenges in driving quality experiences and data, there exists one approach that’s backed by regulatory agencies and proven to lead to better outcomes.
-
Streamlining Study Start-Up For Accelerated Drug Development
2/20/2024
Discover how we accelerated a Phase 1 study’s start-up time by 70%! This case study shares insights on streamlining communication, strategic planning, and more.
-
Trial Rescue: Leadership Approach To Propel Clinical Development
2/16/2024
Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.